Suppression of MMP-9 by doxycycline in brain arteriovenous malformations.

Suppression of MMP-9 by doxycycline in brain arteriovenous malformations.
复制标题

DOI:
10.1186/1471-2377-5-1
复制
发表时间:
2005-01-24
期刊:
影响因子:
2.6
通讯作者:
University of California, San Francisco, BAVM Study Group
University of California, San Francisco, BAVM Study Group
中科院分区:
医学4区
文献类型:
--
作者:
Hashimoto T;Matsumoto MM;Li JF;Lawton MT;Young WL;University of California, San Francisco, BAVM Study Group

文献摘要

参考文献

被引文献

相似文献

本研究的主要目的是证明利用强力霉素抑制脑动静脉畸形(AVM)中基质金属蛋白酶-9(MMP-9)的可行性。AVM组织的离体处理:用多西环素处理完整AVM组织48小时。测定培养基中的活性和总MMP-9。初步试验:AVM患者在AVM切除术前接受强力霉素(100 mg)或安慰剂,每日两次,持续一周。检测BVM组织中活性MMP-9和总MMP-9的含量。AVM组织的离体处理:10和100 μg/ml的多西环素显著降低了离体AVM组织中的MMP-9水平(总:对照vs 10 vs 100 μg/ml = 100 ± 6 vs 60 ± 16 vs 61 ± 9%;活性:100 ± 8 vs 48 ± 16 vs 59 ± 10%)。初步试验:10例患者接受强力霉素,4例患者接受安慰剂。多西环素组的MMP-9水平有低于安慰剂组的趋势(总量:2.18 ± 1.94 vs 3.26 ± 3.58,P = 0.50;活性:0.48 ± 0.48 vs 0.95 ± 1.01 ng/100 μg蛋白,P = 0.25)。临床相关浓度的强力霉素降低了离体AVM组织中的MMP-9。此外,有一种趋势,口服强力霉素短至一周导致AVM组织中MMP-9的降低。进一步的研究是必要的,以证明临床试验,以测试多西环素对MMP-9的表达在AVM组织的影响。
The primary aim of this study is to demonstrate the feasibility of utilizing doxycycline to suppress matrix metalloproteinase-9 (MMP-9) in brain arteriovenous malformations (AVMs). Ex-vivo treatment of AVM tissues: Intact AVM tissues were treated with doxycycline for 48 hours. Active and total MMP-9 in the medium were measured. Pilot trial: AVM patients received either doxycycline (100 mg) or placebo twice a day for one week prior to AVM resection. Active and total MMP-9 in BVM tissues were measured. Ex-vivo treatment of AVM tissues: Doxycycline at 10 and 100 μg/ml significantly decreased MMP-9 levels in AVM tissues ex-vivo (total: control vs 10 vs 100 μg/ml = 100 ± 6 vs 60 ± 16 vs 61 ± 9%; active: 100 ± 8 vs 48 ± 16 vs 59 ± 10%). Pilot trial: 10 patients received doxycycline, and 4 patients received placebo. There was a trend for both MMP-9 levels to be lower in the doxycycline group than in the placebo group (total: 2.18 ± 1.94 vs 3.26 ± 3.58, P = .50; active: 0.48 ± 0.48 vs 0.95 ± 1.01 ng/100 μg protein, P = .25). A clinically relevant concentration of doxycycline decreased MMP-9 in ex-vivo AVM tissues. Furthermore, there was a trend that oral doxycycline for as short as one week resulted in a decrease in MMP-9 in AVM tissues. Further studies are warranted to justify a clinical trial to test effects of doxycycline on MMP-9 expression in AVM tissues.
DOI: 10.1097/00006123-199709000-00027
发表时间: 1997-09-01
期刊: NEUROSURGERY
影响因子: 4.8
作者:
Kim, SC;Singh, M;Connolly, ES
通讯作者: Connolly, ES
DOI: 10.1172/jci117619
发表时间: 1994-12-01
影响因子: 15.9
作者:
GALIS, ZS;SUKHOVA, GK;LIBBY, P
通讯作者: LIBBY, P
DOI: 10.1016/s0741-5214(00)90163-0
发表时间: 2000-02-01
影响因子: 4.3
作者:
Curci, JA;Mao, DL;Thompson, RW
通讯作者: Thompson, RW
DOI: 10.1067/mva.2002.123757
发表时间: 2002-05-01
影响因子: 4.3
作者:
Prall, AK;Longo, GM;Baxter, BT
通讯作者: Baxter, BT
DOI: 10.1227/01.neu.0000103421.35266.71
发表时间: 2004-02-01
期刊: NEUROSURGERY
影响因子: 4.8
作者:
Hashimoto, T;Lawton, MT;Young, WL
通讯作者: Young, WL